SLC39A6: a potential target for diagnosis and therapy of esophageal carcinoma

Overview of attention for article published in Journal of Translational Medicine, October 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

twitter: 1 X user

patent: 1 patent

Citations

dimensions_citation: 25 Dimensions

Readers on

mendeley: 33 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

DEGRADATION OF EGFR USING A BISPECIFIC BINDING AGENT

Application WO-2024036333-A2

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.